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SffORT COMMUNICATION 
HB SETIF [a94(GI)ASP+TYR] IN MALTA 
Since testing of newborn infants for abnormal hemoglobins (Hbs) was 
reinitiated in Malta in 1989, about 20,000 cord blood samples have been 
studied with an isoelectrofocusing (IEF) technique (1). Among these, 2% 
have an abnormal Hb, i.e. 1.8% have a y-globin variant, and 0.2% have an 
a-globin variant (2). P-Globin variants have been noted only sporadically. 
In a further survey for hemoglobinopathies in elderly members of the Maltese 
population, the presence of two a-globin variants that differed in amount and 
electrophoretic mobility, was noted (Fig. 1). One had a pl and peptide map 
consistent with that of Hb St. Luke’s [a95(G2)Pro+Arg] which occurs at 
levels of around 10% of total Hb in heterozygotes from Malta (3,4). The other 
had a slower electrophoretic mobility and was more abundant in the red cell 
lysate. It was present in the proband, a healthy 88-year-old male, and in his 
healthy 91 -year-old sister. 
Methods for hematological analysis and Hb identification, quantifi- 
cation, and isolation are described in detail in Refs. 1 and 5. Globin chains 
were prepared as described by Clegg et al (6). For peptide mapping, the 
globin fractions were dialyzed against distilled water and 0.1 % acetic acid. 
and digested with TPCK-trypsin for 18 hours at room temperature and pH 8.9. 
The tryptic peptides were then separated by reversed phase high perfor- 
mance liquid chromatography (HPLC) using a 1 mg sample and a Pep RPC 
HR 5/5 column (Pharmacia-LKB, Uppsala, Sweden). The chroma-togram 
was developed with a gradient of 0 to 55% acetonitrile in 0.1% aque-ous 
trifluoroacetic acid (TFA) over 120 minutes. The abnormal peptide was 
isolated, lyophilized, and analyzed on an amino acid sequencer (Porton 
Instruments, Tarzana, CA, USA) centered at a wavelength of 269 nm. The 
sequencer was set to automatically analyze up to 16 cycles and calibration, 
in terms of retention times, was done on 20 phenylthiohydantoin (PTH) amino 
acids (except cysteine) with chromatograms coming off from an on-line Hew- 
lett Packard 3396A computing integrator (Hewlett Packard S.A., Geneva 
Switzerland). Alpha lactalbumin (Sigma Chemicals, St. Louis, MO, USA) was 
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FIGURE 1 
IEF of red cell lysates of a Hb St. Luke's heterozygote (lane 1), the proband 
with Hb Setif (lane 2), and an adult with normal Hb (lane 3). 
TABLE I 
Hematological and Hb Composition Data for the Proband and His Sibling 
~ 
Sex- RBC PCV Hb MCH MCV MCHC X, A2 X 
Age 101*/1 1/1 g/dl pg fl g/dl % % % 
M-88 4.30 0.36 12.3 28.6 83.9 34.1 0.55 2.18 16.0 
F-91 4.28 0.37 12.4 29.0 87.4 33.2 0.70 2.36 16.3 
used as a protein standard for all sequencer-run comparisons and was 
dissolved in 20% acetonitrile by vortexing. The system was run on conven- 
tional Edman chemistry as used in the Porton sequencer, employing 5% 
phenylisothiocyanate in heptane as the coupling agent and 4% triethylamine 
(TEA) in water as the coupling base. A 10 PI aliquot of each peptide sample 
was spotted on an 8 mm Porton peptide support, prewetted in 10% acetoni- 
trile, and dried in nitrogen prior to running the procedure. Chromatograms 
were developed on a reverse phase Hewlett Packard AminoQuant (C,& 
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FIGURE 2 
Chromatography showing the reversed phase HPLC separation of peptides 
obtained from the tryptic digestion of (a) the anomalous, and (b) the normal 
a-globin chains. One mg globin was applied on a Pep RPC HR 5/5 column 
(Pharmacia-LKB). The chromatogram was developed with a gradient of 0 to 
55% acetonitrile in 0.1 % aqueous TFA over 120 minutes. 
0.21 x 20 cm narrow bore column kept at 42"C, run isocratically with a devel- 
oper consisting of 100% acetonitrile as buffer B and a mix of 3.5% tetrahydro- 
furan (THF)/water, 29 ml 3 M sodium acetate, and 100 pl TEA, to a final pH 
of 3.9, as buffer A. 
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TABLE II 
Amino Acid Sequence of the Normal and Abnormal aT-I  1 Peptides 
Residue 93 94 95 96 97 98 99 
Normal VAL ASP PRO VAL ASN PHE LYS 
Abnormal VAL TYR PRO VAL ASN PHE LYS 
The proband and his sister had normal hematology without any evi- 
dence of thalassemia or hemolytic disease (Table l). The Hb electrophoresis 
pattern contained an abnormal fraction which averaged 17% of the total Hb 
in the hemolysates from both probands. This value is nearly double that 
found in Hb St. Luke’s heterozygotes (3,4). 
Chromatography of tryptic peptides of the a-globin revealed an abnor- 
mal aT-I 1 peptide (Fig. 2). The amino acid sequence of the abnormal pep- 
tide (aT-I 1) was identical to that described for Hb Setif with an aspartic acid 
residue replacing a tyrosine residue at position 94 of the a-globin polypeptide 
(Table II) (2,3). 
Although this is the first report of Hb Setif in the Central Mediterranean 
islands of Malta and Gozo, this variant is well-known around the Mediterra- 
nean littoral. It was first described in an Algerian male and his family (7,8), 
and subsequently in Cyprus, Sicily, and Spain (9-1 1). It has also been found 
among the Maltese migrant population in Australia (M.N. Cauchi, personal 
communication). 
It is of interest that linguists and social anthropologists trace the 
origins of the Maltese language to the flow of migration from Maghreb to 
Sicily, and later southwards to Malta and Gozo (12). It seems likely that Hb 
Setif and its molecular haplotypes may be a suitable marker for population 
and gene movements in the Central Mediterranean. 
Hb Setif has no pathological effect on hematological values. Indeed, 
in the absence of an a-thalassemia (thal), the rather high value for an a- 
globin variant (average 17%) indicated that it is effectively assembled in 
heterodimers and that the tetramers are stable in vivo. Although the 
substitution at a95(G2)Pro in St. Luke’s [‘Arg; (3)], Hb G-Georgia [+Leu 
(13)], and Hb Rampa [-tSer (14)] result in considerable dissociation of 
tetramers and dimers, this does not seem to be the case with substitutions at 
a94(GI)Asp which occur in Hb Setif (pTyr; 16%) and Hb Sunshine Seth 
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[+His; 17.2% (15)] since the a94 position does not participate in a l p 1  
contacts. The high value reported for Hb Titusville [-+Am; 34.7%; MCV 78 
fl (16)] is likely due to an associated a-thal. 
We thank all the nursing staff at the St. Vincent de Paule Residential 
Home for the Elderly, Paola, Malta. Our sincerest thanks is reserved for all 
those residents who collaborated in the study. 
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